Compare BHVN & ESTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BHVN | ESTA |
|---|---|---|
| Founded | 2013 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Specialties |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 2.0B |
| IPO Year | 2022 | 2018 |
| Metric | BHVN | ESTA |
|---|---|---|
| Price | $13.52 | $84.43 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 14 | 7 |
| Target Price | $29.08 | ★ $86.86 |
| AVG Volume (30 Days) | ★ 3.2M | 432.7K |
| Earning Date | 05-11-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 26.08 | ★ 42.67 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $61,208,000.00 |
| Revenue This Year | N/A | $28.05 |
| Revenue Next Year | N/A | $26.21 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 76.49 |
| 52 Week Low | $7.48 | $33.35 |
| 52 Week High | $18.57 | $86.00 |
| Indicator | BHVN | ESTA |
|---|---|---|
| Relative Strength Index (RSI) | 69.34 | 66.35 |
| Support Level | $13.41 | $63.71 |
| Resistance Level | $13.54 | N/A |
| Average True Range (ATR) | 0.91 | 4.94 |
| MACD | 0.26 | 0.76 |
| Stochastic Oscillator | 81.98 | 93.87 |
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder and others. Its pipeline products include: BHV-2000, BHV-7000, BHV-2100, BHV-8000, BHV-1310, BHV-1300, BHV-1400, BHV-1600, BHV-1530, and BHV-1500.
Establishment Labs Holdings Inc is a medical technology company engaged in offering medical devices and aesthetic products. It is involved in the designing, manufacturing, and marketing of silicone-filled breast and body-shaping implants. The company markets its products under Motiva implants Brand. It distributes its products to medical distributors; and physicians, hospitals, and clinics in the form of direct sales. Its geographical segments are Europe, Latin America, Asia-Pacific/Middle East, and Others.